X. Liu

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.

S. Kopetz, D. Hong, M. Overman, 2019 .

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy

D. Zang, Q. Dou, Jinbao Liu, 2016, Oncogene.

Combined FV and FVIII deficiency (F5F8D) in a Chinese family with a novel missense mutation in MCFD2 gene

Z. Sun, X. Liu, J. Wu, 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

Novel strategies to augment genetically delivered immunotoxin molecular therapy for cancer therapy

Q. Huang, S. Zhang, C. Li, 2009, Cancer Gene Therapy.

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

S. Kopetz, D. Hong, M. Overman, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Study on discrete relaxation time spectrum for PBO/PPA liquid crystal polymer solution

Q. Zhuang, J. Qian, X. Liu, 2014 .

Successful abdominal operation without replacement therapy in a patient with combined factor V (FV) and FVIII deficiency due to novel homozygous mutation in LMAN1

K. Ding, Z. Sun, X. Liu, 2015, Haemophilia : the official journal of the World Federation of Hemophilia.

The rheological properties of bamboo cellulose pulp/ionic liquid system

Q. Jia, J. Wu, P. Zhang, 2016 .

Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations

F. Meric-Bernstam, T. Shen, B. Mooers, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response

K. Hess, F. Meric-Bernstam, R. Kurzrock, 2015, BMC Cancer.